Sally Susman - Mar 4, 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
/s/ Shanice A. Reid, by power of atty, for Sally Susman
Stock symbol
PFE
Transactions as of
Mar 4, 2025
Transactions value $
$0
Form type
4
Date filed
3/6/2025, 01:56 PM
Previous filing
Mar 3, 2025
Next filing
Mar 12, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Award $0 +157K $0.00 157K Mar 4, 2025 Common Stock 157K $25.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.